TY - JOUR
T1 - Transitions in electronic cigarette use among adults in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1 and 2 (2013-2015)
AU - Coleman, Blair
AU - Rostron, Brian
AU - Johnson, Sarah E.
AU - Persoskie, Alexander
AU - Pearson, Jennifer
AU - Stanton, Cassandra
AU - Choi, Kelvin
AU - Anic, Gabriella
AU - Goniewicz, MacIej Lukasz
AU - Cummings, Kenneth Michael
AU - Kasza, Karin A.
AU - Silveira, Marushka L.
AU - Delnevo, Cristine
AU - Niaura, Raymond
AU - Abrams, David B.
AU - Kimmel, Heather L.
AU - Borek, Nicolette
AU - Compton, Wilson M.
AU - Hyland, Andrew
N1 - Funding Information:
J&J and grant support from Pfizer. RN served as an expert witness for plaintiff versus tobacco companies. JLP serves as a consultant for plaintiff versus tobacco companies. WMC reports holding stock in General Electric, and 3M Companies and Pfizer. KMC has received grant funding from the Pfizer, Inc., to study the impact of a hospital based tobacco cessation intervention. KMC also receives funding as an expert witness in litigation filed against the tobacco industry. No financial disclosures were reported by the other authors of this paper.
Funding Information:
Funding This manuscript is supported with Federal funds from the National Institute on Drug Abuse, National Institutes of Health and the Center for Tobacco Products, Food and Drug Administration, Department of Health and Human Services, under a contract to Westat (Contract No. HHSN271201100027C).
Funding Information:
The PATH Study is an ongoing, nationally representative, longitudinal cohort study of adults and youth in USA. The National Institutes of Health, through the National Institute on Drug Abuse, is partnering with the Food and Drug Administration’s Center for Tobacco Products to conduct the PATH Study under a contract with Westat.
Funding Information:
This manuscript is supported with Federal funds from the National Institute on Drug Abuse, National Institutes of Health and the Center for Tobacco Products, Food and Drug Administration, Department of Health and Human Services, under a contract to Westat (Contract No. HHSN271201100027C).
Publisher Copyright:
© 2019 Article (S).
PY - 2019/1
Y1 - 2019/1
N2 - Introduction This study assessed patterns of e-cigarette and cigarette use from Wave 1 to Wave 2 among adult e-cigarette users at Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study. Methods We examined changes in e-cigarette use frequency at Wave 2 among adult e-cigarette users at Wave 1 (unweighted n=2835). Adjusted prevalence ratios (aPR) were calculated using a predicted marginal probability approach to assess correlates of e-cigarette discontinuance and smoking abstinence at Wave 2. Results Half (48.8%) of adult e-cigarette users at Wave 1 discontinued their use of e-cigarettes at Wave 2. Among dual users of e-cigarettes and cigarettes at Wave 1, 44.3% maintained dual use, 43.5% discontinued e-cigarette use and maintained cigarette smoking and 12.1% discontinued cigarette use at Wave 2, either by abstaining from cigarette smoking only (5.1%) or discontinuing both products (7.0%). Among dual users at Wave 1, daily e-cigarette users were more likely than non-daily users to report smoking abstinence at Wave 2 (aPR=1.40, 95% CI 1.02 to 1.91). Using a customisable device (rather than a non-customisable one) was not significantly related to smoking abstinence at Wave 2 (aPR=1.14, 95% CI 0.81 to 1.60). Conclusions This study suggests that e-cigarette use patterns are highly variable over a 1-year period. This analysis provides the first nationally representative estimates of transitions among US adult e-cigarette users. Future research, including additional waves of the PATH Study, can provide further insight into long-term patterns of e-cigarette use critical to understanding the net population health impact of e-cigarettes in USA.
AB - Introduction This study assessed patterns of e-cigarette and cigarette use from Wave 1 to Wave 2 among adult e-cigarette users at Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study. Methods We examined changes in e-cigarette use frequency at Wave 2 among adult e-cigarette users at Wave 1 (unweighted n=2835). Adjusted prevalence ratios (aPR) were calculated using a predicted marginal probability approach to assess correlates of e-cigarette discontinuance and smoking abstinence at Wave 2. Results Half (48.8%) of adult e-cigarette users at Wave 1 discontinued their use of e-cigarettes at Wave 2. Among dual users of e-cigarettes and cigarettes at Wave 1, 44.3% maintained dual use, 43.5% discontinued e-cigarette use and maintained cigarette smoking and 12.1% discontinued cigarette use at Wave 2, either by abstaining from cigarette smoking only (5.1%) or discontinuing both products (7.0%). Among dual users at Wave 1, daily e-cigarette users were more likely than non-daily users to report smoking abstinence at Wave 2 (aPR=1.40, 95% CI 1.02 to 1.91). Using a customisable device (rather than a non-customisable one) was not significantly related to smoking abstinence at Wave 2 (aPR=1.14, 95% CI 0.81 to 1.60). Conclusions This study suggests that e-cigarette use patterns are highly variable over a 1-year period. This analysis provides the first nationally representative estimates of transitions among US adult e-cigarette users. Future research, including additional waves of the PATH Study, can provide further insight into long-term patterns of e-cigarette use critical to understanding the net population health impact of e-cigarettes in USA.
KW - electronic nicotine delivery devices
KW - non-cigarette tobacco products
KW - surveillance and monitoring
UR - http://www.scopus.com/inward/record.url?scp=85058750951&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058750951&partnerID=8YFLogxK
U2 - 10.1136/tobaccocontrol-2017-054174
DO - 10.1136/tobaccocontrol-2017-054174
M3 - Article
C2 - 29695458
AN - SCOPUS:85058750951
SN - 0964-4563
VL - 28
SP - 50
EP - 59
JO - Tobacco Control
JF - Tobacco Control
IS - 1
ER -